MX1 - $6.18m Placement
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The funds will primarily support commercial activities in medical imaging and manufacturing scale-up, including the productization of their Head CT technology. The placement is part of Micro-X's renewed strategic focus on medical imaging, which has shown growing commercial momentum.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Micro-X
- Trading Halt
- Micro-X Unveils Updated Rover Mobile X-ray System Ahead of International Debut at RSNA 2025
- MX1 - Micro-X Receives $5.1 Million R&D Tax Incentive
- MX1 - $3.3M Rover Plus Order from Malaysian MOH
- MX1 - Head CT Milestone - Proceeding to Imaging Trial
Later from Micro-X
- MX1 - Quarterly Activities Report & Appendix 4C
- MX1 - Head CT First Human Pilot Site at Royal Melbourne
- MX1 - Response to Publication on Government Website
- MX1 - Appendix 4D and Half Year Financial Statements
- MX1 - December 2025 Half Year Results Presentation
Follow Micro-X into a list and get an email when it puts out news.
Follow Micro-X